Seroprevalence of Measles- and Mumps-Specific Immunoglobulin G among Japanese Healthcare Students Increased during 2007–2012

DOI Web Site PubMed 被引用文献2件
  • Kimura Takao
    Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine
  • Tsunekawa Katsuhiko
    Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine
  • Ogiwara Takayuki
    Infection Control and Prevention Center, Gunma University Hospital
  • Tokue Yutaka
    Infection Control and Prevention Center, Gunma University Hospital
  • Nara Makoto
    Infection Control and Prevention Center, Gunma University Hospital
  • Inoue Toshiya
    Clinical Laboratory Center, Gunma University Hospital
  • Obuchi Toshiko
    Infection Control and Prevention Center, Gunma University Hospital
  • Suto Chiaki
    Clinical Laboratory Center, Gunma University Hospital
  • Ohshima Kihachi
    Gunma University, Health and Medical Center
  • Murakami Masami
    Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine Infection Control and Prevention Center, Gunma University Hospital Clinical Laboratory Center, Gunma University Hospital

書誌事項

タイトル別名
  • Seroprevalence of Measles- and Mumps-Specific Immunoglobulin G among Japanese Healthcare Students Increased during 2007–2012

この論文をさがす

抄録

We evaluated the seroprevalence of vaccine-preventable infectious diseases among Japanese healthcare students to create immunization guidelines. Between 2007 and 2012, a total of 1746 Japanese medical, nursing, and paramedical students were serologically screened for measles, mumps, rubella, varicella, and hepatitis B virus (HBV) antibodies at the time of admission. In 2007, the seroprevalence of measles and mumps was 52.7% and 65.6%, respectively. The seroprevalence of measles dramatically increased to 96.6% in 2009 and was then sustained at >90%. The seroprevalence of mumps gradually increased to >80.0% between 2010 and 2012. The seroprevalence of rubella remained at >90% except in 2008 (85.6%), and the seroprevalence of varicella was sustained at >92% throughout 2007–2012. The seroprevalence of HBV antibody remained at <7% during 2007–2012. Although the seroprevalence of vaccine-preventable infectious diseases among Japanese healthcare students increased during the 2007–2012 study period, a substantial number of students were susceptible to vaccine-preventable infectious diseases. Therefore, we propose targeted immunization of Japanese healthcare students using serological screening prior to clinical training.

収録刊行物

被引用文献 (2)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ